Friday 26, Feb 2010
Frailty in older women possible of being treated with appetite-stimulating hormone
Ghrelin, a hormone that stimulates appetite, can be used as an effective option for offering relief to older women suffering from clinical frailty. This finding was revealed by a study presented by Penn Medicine researchers at ENDO, The Endocrine Society’s 91st Annual Meeting.
Frailty is a common geriatric syndrome that is characterized by unintentional weight loss, exhaustion, weakness, and low levels of anabolic hormones prompting increase in risk of falls, hospitalizations, disability, and even death.
Anne Cappola, MD, ScM, Assistant Professor of Medicine in Endocrinology, Diabetes, and Metabolism at the University of Pennsylvania School of Medicine, said that efforts to identify ways for preventing or treating common geriatric conditions has become highly important today due to the associated severe health consequences.
Tags: anabolic, anabolic hormones, frailty, ghrelin, placebo
Posted in Steroid Cycles, steroid nation, Steroids and Anabolic Steroids